Mobilization of hematopoietic stem and leukemia cells

Journal of Leukocyte Biology

Volumn 91, Issue 1, 2012, Pages 47-57

  Schroeder, Mark A ^a   Dipersio, John F ^a  

^a USA   (United States)

Author keywords

CXCR4; Integrins; Niche; Plerixafor AMD3100; Stromal derived factor 1 CXCL12

Indexed keywords

CHEMOKINE RECEPTOR CXCR4;

BONE MARROW; CELL HOMING; ENGRAFTMENT; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA CELL; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL MOBILIZATION; STEM CELL NICHE;

ANIMALS; CELL MOVEMENT; HEMATOPOIETIC STEM CELLS; HOMEOSTASIS; HUMANS; INFLAMMATION; LEUKEMIA;

EID: 84855337388     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0210085     Document Type: Review

References (140)

1. Becker, A. J., McCulloch, E. A., Till, J. E. (1963) Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 197, 452-454.
2. Bonnet, D., Dick, J. E. (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3, 730-737.
3. Dick, J. E. (2008) Stem cell concepts renew cancer research. Blood 112, 4793-4807.
4. Rombouts, E. J., Pavic, B., Lowenberg, B., Ploemacher, R. E. (2004) Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia. Blood 104, 550-557.
5. Spoo, A. C., Lubbert, M., Wierda, W. G., Burger, J. A. (2007) CXCR4 is a prognostic marker in acute myelogenous leukemia. Blood 109, 786-791.
6. Kawabata, K., Ujikawa, M., Egawa, T., Kawamoto, H., Tachibana, K., Iizasa, H., Katsura, Y., Kishimoto, T., Nagasawa, T. (1999) A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proc. Natl. Acad. Sci. USA 96, 5663-5667.
7. Discher, D. E., Mooney, D. J., Zandstra, P. W. (2009) Growth factors, matrices, and forces combine and control stem cells. Science 324, 1673-1677.
8. Kiel, M. J., Yilmaz, O. H., Iwashita, T., Terhorst, C., Morrison, S. J. (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109-1121.
9. Kiel, M. J., Morrison, S. J. (2008) Uncertainty in the niches that maintain haematopoietic stem cells. Nat. Rev. Immunol. 8, 290-301.
10. Zhang, J., Niu, C., Ye, L., Huang, H., He, X., Tong, W. G., Ross, J., Haug, J., Johnson, T., Feng, J. Q., Harris, S., Wiedemann, L. M., Mishina, Y., Li, L. (2003) Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425, 836-841.
11. Adams, G. B., Chabner, K. T., Alley, I. R., Olson, D. P., Szczepiorkowski, Z. M., Poznansky, M. C., Kos, C. H., Pollak, M. R., Brown, E. M., Scadden, D. T. (2006) Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 439, 599-603.
12. Yin, T., Li, L. (2006) The stem cell niches in bone. J. Clin. Invest. 116, 1195-1201.
13. Cheng, T., Rodrigues, N., Shen, H., Yang, Y., Dombkowski, D., Sykes, M., Scadden, D. T. (2000) Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287, 1804-1808.
14. Calvi, L. M., Adams, G. B., Weibrecht, K. W., Weber, J. M., Olson, D. P., Knight, M. C., Martin, R. P., Schipani, E., Divieti, P., Bringhurst, F. R., Milner, L. A., Kronenberg, H. M., Scadden, D. T. (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841-846.
15. Stier, S., Ko, Y., Forkert, R., Lutz, C., Neuhaus, T., Grunewald, E., Cheng, T., Dombkowski, D., Calvi, L. M., Rittling, S. R., Scadden, D. T. (2005) Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J. Exp. Med. 201, 1781-1791.
16. Nilsson, S. K., Johnston, H. M., Whitty, G. A., Williams, B., Webb, R. J., Denhardt, D. T., Bertoncello, I., Bendall, L. J., Simmons, P. J., Haylock, D. N. (2005) Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 106, 1232-1239.
17. Gothot, A., van der Loo, J. C., Clapp, D. W., Srour, E. F. (1998) Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood 92, 2641-2649.
18. Passegué, E., Wagers, A. J., Giuriato, S., Anderson, W. C., Weissman, I. L. (2005) Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J. Exp. Med. 202, 1599-1611.
19. Fleming, W. H., Alpern, E. J., Uchida, N., Ikuta, K., Spangrude, G. J., Weissman, I. L. (1993) Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J. Cell Biol. 122, 897-902.
20. Nilsson, S. K., Johnston, H. M., Coverdale, J. A. (2001) Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 97, 2293-2299.
21. Xie, Y., Yin, T., Wiegraebe, W., He, X. C., Miller, D., Stark, D., Perko, K., Alexander, R., Schwartz, J., Grindley, J. C., Park, J., Haug, J. S., Wunderlich, J. P., Li, H., Zhang, S., Johnson, T., Feldman, R. A., Li, L. (2009) Detection of functional haematopoietic stem cell niche using real-time imaging. Nature 457, 97-101.
22. Lo Celso, C., Fleming, H. E., Wu, J. W., Zhao, C. X., Miake-Lye, S., Fujisaki, J., Cote, D., Rowe, D. W., Lin, C. P., Scadden, D. T. (2009) Liveanimal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 457, 92-96.
23. Arai, F., Hirao, A., Ohmura, M., Sato, H., Matsuoka, S., Takubo, K., Ito, K., Koh, G. Y., Suda, T. (2004) Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118, 149-161.
24. Visnjic, D., Kalajzic, I., Gronowicz, G., Aguila, H. L., Clark, S. H., Lichtler, A. C., Rowe, D. W. (2001) Conditional ablation of the osteoblast lineage in Col2.3δtk transgenic mice. J. Bone Miner. Res. 16, 2222-2231.
25. Kollet, O., Dar, A., Shivtiel, S., Kalinkovich, A., Lapid, K., Sztainberg, Y., Tesio, M., Samstein, R. M., Goichberg, P., Spiegel, A., Elson, A., Lapidot, T. (2006) Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat. Med. 12, 657-664.
26. Gowen, M., Lazner, F., Dodds, R., Kapadia, R., Feild, J., Tavaria, M., Bertoncello, I., Drake, F., Zavarselk, S., Tellis, I., Hertzog, P., Debouck, C., Kola, I. (1999) Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J. Bone Miner. Res. 14, 1654-1663.
27. Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D., Moore, M. A., Werb, Z., Rafii, S. (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109, 625-637.
28. Pruijt, J. F., Verzaal, P., van Os, R., de Kruijf, E. J., van Schie, M. L., Mantovani, A., Vecchi, A., Lindley, I. J., Willemze, R., Starckx, S., Opdenakker, G., Fibbe, W. E. (2002) Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice. Proc. Natl. Acad. Sci. USA 99, 6228-6233.
29. Pruijt, J. F., Fibbe, W. E., Laterveer, L., Pieters, R. A., Lindley, I. J., Paemen, L., Masure, S., Willemze, R., Opdenakker, G. (1999) Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). Proc. Natl. Acad. Sci. USA 96, 10863-10868.
30. Solar, G. P., Kerr, W. G., Zeigler, F. C., Hess, D., Donahue, C., de Sauvage, F. J., Eaton, D. L. (1998) Role of c-mpl in early hematopoiesis. Blood 92, 4-10.
31. Li, W., Johnson, S. A., Shelley, W. C., Yoder, M. C. (2004) Hematopoietic stem cell repopulating ability can be maintained in vitro by some primary endothelial cells. Exp. Hematol. 32, 1226-1237.
32. Sipkins, D. A., Wei, X., Wu, J. W., Runnels, J. M., Cote, D., Means, T. K., Luster, A. D., Scadden, D. T., Lin, C. P. (2005) In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 435, 969-973.
33. Sugiyama, T., Kohara, H., Noda, M., Nagasawa, T. (2006) Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25, 977-988.
34. Méndez-Ferrer, S., Lucas, D., Battista, M., Frenette, P. S. (2008) Haematopoietic stem cell release is regulated by circadian oscillations. Nature 452, 442-447.
35. Katayama, Y., Battista, M., Kao, W. M., Hidalgo, A., Peired, A. J., Thomas, S. A., Frenette, P. S. (2006) Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124, 407-421.
36. Méndez-Ferrer, S., Michurina, T. V., Ferraro, F., Mazloom, A. R., Macarthur, B. D., Lira, S. A., Scadden, D. T., Ma'ayan, A., Enikolopov, G. N., Frenette, P. S. (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829-834.
37. Chow, A., Lucas, D., Hidalgo, A., Mendez-Ferrer, S., Hashimoto, D., Scheiermann, C., Battista, M., Leboeuf, M., Prophete, C., van Rooijen, N., Tanaka, M., Merad, M., Frenette, P. S. (2011) Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J. Exp. Med. 208, 261-271.
38. Jang, Y. Y., Sharkis, S. J. (2007) A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the lowoxygenic niche. Blood 110, 3056-3063.
39. Parmar, K., Mauch, P., Vergilio, J. A., Sackstein, R., Down, J. D. (2007) Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc. Natl. Acad. Sci. USA 104, 5431-5436.
40. Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., Gurtner, G. C. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10, 858-864.
41. Fiegl, M., Samudio, I., Clise-Dwyer, K., Burks, J. K., Mnjoyan, Z., Andreeff, M. (2009) CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure. Blood 113, 1504-1512.
42. Bhattacharya, D., Czechowicz, A., Ooi, A. G., Rossi, D. J., Bryder, D., Weissman, I. L. (2009) Niche recycling through division-independent egress of hematopoietic stem cells. J. Exp. Med. 206, 2837-2850.
43. Chen, J., Larochelle, A., Fricker, S., Bridger, G., Dunbar, C. E., Abkowitz, J. L. (2006) Mobilization as a preparative regimen for hematopoietic stem cell transplantation. Blood 107, 3764-3771.
44. Colmone, A., Amorim, M., Pontier, A. L., Wang, S., Jablonski, E., Sipkins, D. A. (2008) Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 322, 1861-1865.
45. Lapidot, T., Dar, A., Kollet, O. (2005) How do stem cells find their way home? Blood 106, 1901-1910.
46. Mazo, I. B., Gutierrez-Ramos, J. C., Frenette, P. S., Hynes, R. O., Wagner, D. D., von Andrian, U. H. (1998) Hematopoietic progenitor cell rolling in bone marrow microvessels: parallel contributions by endothelial selectins and vascular cell adhesion molecule 1. J. Exp. Med. 188, 465-474.
47. Papayannopoulou, T., Priestley, G. V., Nakamoto, B., Zafiropoulos, V., Scott, L. M. (2001) Molecular pathways in bone marrow homing: dominant role of α(4)β(1) over β(2)-integrins and selectins. Blood 98, 2403-2411.
48. Peled, A., Kollet, O., Ponomaryov, T., Petit, I., Franitza, S., Grabovsky, V., Slav, M. M., Nagler, A., Lider, O., Alon, R., Zipori, D., Lapidot, T. (2000) The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/ stromal migration and engraftment of NOD/SCID mice. Blood 95, 3289-3296.
49. Peled, A., Grabovsky, V., Habler, L., Sandbank, J., Arenzana-Seisdedos, F., Petit, I., Ben-Hur, H., Lapidot, T., Alon, R. (1999) The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. J. Clin. Invest. 104, 1199-1211.
50. Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., Lider, O., Alon, R., Zipori, D., Lapidot, T. (1999) Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283, 845-848.
51. Kollet, O., Spiegel, A., Peled, A., Petit, I., Byk, T., Hershkoviz, R., Guetta, E., Barkai, G., Nagler, A., Lapidot, T. (2001) Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/ SCID/B2m(null) mice. Blood 97, 3283-3291.
52. Imai, K., Kobayashi, M., Wang, J., Ohiro, Y., Hamada, J., Cho, Y., Imamura, M., Musashi, M., Kondo, T., Hosokawa, M., Asaka, M. (1999) Selective transendothelial migration of hematopoietic progenitor cells: a role in homing of progenitor cells. Blood 93, 149-156.
53. Avigdor, A., Goichberg, P., Shivtiel, S., Dar, A., Peled, A., Samira, S., Kollet, O., Hershkoviz, R., Alon, R., Hardan, I., Ben-Hur, H., Naor, D., Nagler, A., Lapidot, T. (2004) CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood 103, 2981-2989.
54. Dimitroff, C. J., Lee, J. Y., Fuhlbrigge, R. C., Sackstein, R. (2000) A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. Proc. Natl. Acad. Sci. USA 97, 13841-13846.
55. Dimitroff, C. J., Lee, J. Y., Rafii, S., Fuhlbrigge, R. C., Sackstein, R. (2001) CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J. Cell Biol. 153, 1277-1286.
56. Papayannopoulou, T., Craddock, C., Nakamoto, B., Priestley, G. V., Wolf, N. S. (1995) The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc. Natl. Acad. Sci. USA 92, 9647-9651.
57. Vermeulen, M., Le Pesteur, F., Gagnerault, M. C., Mary, J. Y., Sainteny, F., Lepault, F. (1998) Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells. Blood 92, 894-900.
58. Williams, D. A., Rios, M., Stephens, C., Patel, V. P. (1991) Fibronectin and VLA-4 in haematopoietic stem cell-microenvironment interactions. Nature 352, 438-441.
59. Wright, D. E., Wagers, A. J., Gulati, A. P., Johnson, F. L., Weissman, I. L. (2001) Physiological migration of hematopoietic stem and progenitor cells. Science 294, 1933-1936.
60. Pelus, L. M., Fukuda, S. (2008) Chemokine-mobilized adult stem cells; defining a better hematopoietic graft. Leukemia 22, 466-473.
61. Broxmeyer, H. E. (2008) Chemokines in hematopoiesis. Curr. Opin. Hematol. 15, 49-58.
62. Nervi, B., Link, D. C., DiPersio, J. F. (2006) Cytokines and hematopoietic stem cell mobilization. J. Cell. Biochem. 99, 690-705.
63. Wright, D. E., Bowman, E. P., Wagers, A. J., Butcher, E. C., Weissman, I. L. (2002) Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J. Exp. Med. 195, 1145-1154.
64. Broxmeyer, H. E., Orschell, C. M., Clapp, D. W., Hangoc, G., Cooper, S., Plett, P. A., Liles, W. C., Li, X., Graham-Evans, B., Campbell, T. B., Calandra, G., Bridger, G., Dale, D. C., Srour, E. F. (2005) Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J. Exp. Med. 201, 1307-1318.
65. Semerad, C. L., Christopher, M. J., Liu, F., Short, B., Simmons, P. J., Winkler, I., Levesque, J. P., Chappel, J., Ross, F. P., Link, D. C. (2005) G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106, 3020-3027.
66. Petit, I., Szyper-Kravitz, M., Nagler, A., Lahav, M., Peled, A., Habler, L., Ponomaryov, T., Taichman, R. S., Arenzana-Seisdedos, F., Fujii, N., Sandbank, J., Zipori, D., Lapidot, T. (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3, 687-694.
67. Lévesque, J. P., Hendy, J., Takamatsu, Y., Simmons, P. J., Bendall, L. J. (2003) Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J. Clin. Invest. 111, 187-196.
68. Laterveer, L., Lindley, I. J., Hamilton, M. S., Willemze, R., Fibbe, W. E. (1995) Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood 85, 2269-2275.
69. Laterveer, L., Lindley, I. J., Heemskerk, D. P., Camps, J. A., Pauwels, E. K., Willemze, R., Fibbe, W. E. (1996) Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood 87, 781-788.
70. Pruijt, J. F., Willemze, R., Fibbe, W. E. (1999) Mechanisms underlying hematopoietic stem cell mobilization induced by the CXC chemokine interleukin-8. Curr. Opin. Hematol. 6, 152-158.
71. Pruijt, J. F., van Kooyk, Y., Figdor, C. G., Lindley, I. J., Willemze, R., Fibbe, W. E. (1998) Anti-LFA-1 blocking antibodies prevent mobilization of hematopoietic progenitor cells induced by interleukin-8. Blood 91, 4099-4105.
72. Fukuda, S., Bian, H., King, A. G., Pelus, L. M. (2007) The chemokine GROβ mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment. Blood 110, 860-869.
73. Pelus, L. M., Fukuda, S. (2006) Peripheral blood stem cell mobilization: the CXCR2 ligand GROβ rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties. Exp. Hematol. 34, 1010-1020.
74. Liles, W. C., Broxmeyer, H. E., Rodger, E., Wood, B., Hubel, K., Cooper, S., Hangoc, G., Bridger, G. J., Henson, G. W., Calandra, G., Dale, D. C. (2003) Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 102, 2728-2730.
75. Liles, W. C., Rodger, E., Broxmeyer, H. E., Dehner, C., Badel, K., Calandra, G., Christensen, J., Wood, B., Price, T. H., Dale, D. C. (2005) Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist. Transfusion 45, 295-300.
76. Devine, S. M., Vij, R., Rettig, M., Todt, L., McGlauchlen, K., Fisher, N., Devine, H., Link, D. C., Calandra, G., Bridger, G., Westervelt, P., Dipersio, J. F. (2008) Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction. Blood 112, 990-998.
77. Devine, S. M., Flomenberg, N., Vesole, D. H., Liesveld, J., Weisdorf, D., Badel, K., Calandra, G., DiPersio, J. F. (2004) Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma. J. Clin. Oncol. 22, 1095-1102.
78. Hess, D. A., Bonde, J., Craft, T. P., Wirthlin, L., Hohm, S., Lahey, R., Todt, L. M., Dipersio, J. F., Devine, S. M., Nolta, J. A. (2007) Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor. Biol. Blood Marrow Transplant. 13, 398-411.
79. Devine, S. M., Liu, F., Holt, M., Link, D., DiPersio, J. (2003) AMD3100- mobilized murine hematopoietic stem cells and T-lymphocytes have identical capacity to induce multilineage stem cell engraftment, donor T-cell chimerism and GVHD in mice compared with G-CSF mobilized cells. Blood (ASH Annual Meeting Abstracts) 102, Abs. 3495.
80. Cashen, A., Lopez, S., Gao, F., Calandra, G., MacFarland, R., Badel, K., DiPersio, J. (2008) A phase II study of plerixafor (AMD3100) plus GCSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma. Biol. Blood Marrow Transplant. 14, 1253-1261.
81. Flomenberg, N., Devine, S. M., Dipersio, J. F., Liesveld, J. L., McCarty, J. M., Rowley, S. D., Vesole, D. H., Badel, K., Calandra, G. (2005) The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 106, 1867-1874.
82. Ramirez, P., Rettig, M. P., Uy, G. L., Deych, E., Holt, M. S., Ritchey, J. K., DiPersio, J. F. (2009) BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells. Blood 114, 1340-1343.
83. Bonig, H., Watts, K. L., Chang, K. H., Kiem, H. P., Papayannopoulou, T. (2009) Concurrent blockade of α4-integrin and CXCR4 in hematopoietic stem/progenitor cell mobilization. Stem Cells 27, 836-837.
84. Papayannopoulou, T., Priestley, G. V., Nakamoto, B. (1998) Anti-VLA4/ VCAM-1-induced mobilization requires cooperative signaling through the kit/mkit ligand pathway. Blood 91, 2231-2239.
85. Martelli, F., Verrucci, M., Migliaccio, G., Zingariello, M., Rana, R. A., Vannucchi, A. M., Migliaccio, A. R. (2009) Removal of the spleen in mice alters the cytokine expression profile of the marrow micro-environment and increases bone formation. Ann. N. Y. Acad. Sci. 1176, 77-86.
86. Ratajczak, J., Reca, R., Kucia, M., Majka, M., Allendorf, D. J., Baran, J. T., Janowska-Wieczorek, A., Wetsel, R. A., Ross, G. D., Ratajczak, M. Z. (2004) Mobilization studies in mice deficient in either C3 or C3a receptor (C3aR) reveal a novel role for complement in retention of hematopoietic stem/progenitor cells in bone marrow. Blood 103, 2071-2078.
87. Lee, H. M., Wysoczynski, M., Liu, R., Shin, D. M., Kucia, M., Botto, M., Ratajczak, J., Ratajczak, M. Z. (2010) Mobilization studies in complement- deficient mice reveal that optimal AMD3100 mobilization of hematopoietic stem cells depends on complement cascade activation by AMD3100-stimulated granulocytes. Leukemia 24, 573-582.
88. Jalili, A., Shirvaikar, N., Marquez-Curtis, L., Qiu, Y., Korol, C., Lee, H., Turner, A. R., Ratajczak, M. Z., Janowska-Wieczorek, A. (2010) Fifth complement cascade protein (C5) cleavage fragments disrupt the SDF- 1/CXCR4 axis: further evidence that innate immunity orchestrates the mobilization of hematopoietic stem/progenitor cells. Exp. Hematol. 38, 321-332.
89. Reca, R., Cramer, D., Yan, J., Laughlin, M. J., Janowska-Wieczorek, A., Ratajczak, J., Ratajczak, M. Z. (2007) A novel role of complement in mobilization: immunodeficient mice are poor granulocyte-colony stimulating factor mobilizers because they lack complement-activating immunoglobulins. Stem Cells 25, 3093-3100.
90. Lee, H. M., Wu, W., Wysoczynski, M., Liu, R., Zuba-Surma, E. K., Kucia, M., Ratajczak, J., Ratajczak, M. Z. (2009) Impaired mobilization of hematopoietic stem/progenitor cells in C5-deficient mice supports the pivotal involvement of innate immunity in this process and reveals novel promobilization effects of granulocytes. Leukemia 23, 2052-2062.
91. Christopher, M. J., Rao, M., Liu, F., Woloszynek, J. R., Link, D. C. (2011) Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. J. Exp. Med. 208, 251-260.
92. Pelus, L. M., Bian, H., King, A. G., Fukuda, S. (2004) Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GROβ/CXCL2 and GROβT/CXCL2δ4. Blood 103, 110-119.
93. Winkler, I. G., Sims, N. A., Pettit, A. R., Barbier, V., Nowlan, B., Helwani, F., Poulton, I. J., van Rooijen, N., Alexander, K. A., Raggatt, L. J., Levesque, J. P. (2010) Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSCs. Blood 116, 4815-4828.
94. Cleary, M. L. (2009) Regulating the leukaemia stem cell. Best Pract. Res. Clin. Haematol. 22, 483-487.
95. Sarry, J-E., Murphy, K., Danet-Desnoyers, G., Carroll, M. (2009) Acute myeloid leukemia stem cells are rare and heterogeneous in human acute myeloid leukemia. Blood (ASH Annual Meeting Abstracts) 114, Abs. 390.
96. Somervaille, T. C., Matheny, C. J., Spencer, G. J., Iwasaki, M., Rinn, J. L., Witten, D. M., Chang, H. Y., Shurtleff, S. A., Downing, J. R., Cleary, M. L. (2009) Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. Cell Stem Cell 4, 129-140.
97. Panayiotidis, P., Jones, D., Ganeshaguru, K., Foroni, L., Hoffbrand, A. V. (1996) Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br. J. Haematol. 92, 97-103.
98. Damiano, J. S., Cress, A. E., Hazlehurst, L. A., Shtil, A. A., Dalton, W. S. (1999) Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood 93, 1658-1667.
99. Konopleva, M., Konoplev, S., Hu, W., Zaritskey, A. Y., Afanasiev, B. V., Andreeff, M. (2002) Stromal cells prevent apoptosis of AML cells by upregulation of anti-apoptotic proteins. Leukemia 16, 1713-1724.
100. Matsunaga, T., Takemoto, N., Sato, T., Takimoto, R., Tanaka, I., Fujimi, A., Akiyama, T., Kuroda, H., Kawano, Y., Kobune, M., Kato, J., Hirayama, Y., Sakamaki, S., Kohda, K., Miyake, K., Niitsu, Y. (2003) Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat. Med. 9, 1158-1165.
101. Nefedova, Y., Landowski, T. H., Dalton, W. S. (2003) Bone marrow stromal- derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms. Leukemia 17, 1175-1182.
102. Hazlehurst, L. A., Argilagos, R. F., Emmons, M., Boulware, D., Beam, C. A., Sullivan, D. M., Dalton, W. S. (2006) Cell adhesion to fibronectin (CAM-DR) influences acquired mitoxantrone resistance in U937 cells. Cancer Res. 66, 2338-2345.
103. Taussig, D. C., Vargaftig, J., Miraki-Moud, F., Griessinger, E., Sharrock, K., Luke, T., Lillington, D., Oakervee, H. E., Cavenagh, J., Agrawal, S. G., Lister, T. A., Gribben, J. G., Bonnet, D. (2010) Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction. Blood 115, 1976-1984.
104. Konoplev, S., Rassidakis, G. Z., Estey, E., Kantarjian, H., Liakou, C. I., Huang, X., Xiao, L., Andreeff, M., Konopleva, M., Medeiros, L. J. (2007) Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype. Cancer 109, 1152-1156.
105. Guan, Y., Gerhard, B., Hogge, D. E. (2003) Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood 101, 3142-3149.
106. Möhle, R., Bautz, F., Rafii, S., Moore, M. A., Brugger, W., Kanz, L. (1998) The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 91, 4523-4530.
107. Tavor, S., Petit, I., Porozov, S., Avigdor, A., Dar, A., Leider-Trejo, L., Shemtov, N., Deutsch, V., Naparstek, E., Nagler, A., Lapidot, T. (2004) CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice. Cancer Res. 64, 2817-2824.
108. Möhle, R., Schittenhelm, M., Failenschmid, C., Bautz, F., Kratz-Albers, K., Serve, H., Brugger, W., Kanz, L. (2000) Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia. Br. J. Haematol. 110, 563-572.
109. Tavor, S., Petit, I., Porozov, S., Goichberg, P., Avigdor, A., Sagiv, S., Nagler, A., Naparstek, E., Lapidot, T. (2005) Motility, proliferation, and egress to the circulation of human AML cells are elastase dependent in NOD/SCID chimeric mice. Blood 106, 2120-2127.
110. Shen, W., Bendall, L. J., Gottlieb, D. J., Bradstock, K. F. (2001) The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhe-sion and facilitates engraftment of leukemic precursor-B cells in the bone marrow. Exp. Hematol. 29, 1439-1447.
111. Charrad, R. S., Li, Y., Delpech, B., Balitrand, N., Clay, D., Jasmin, C., Chomienne, C., Smadja-Joffe, F. (1999) Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia. Nat. Med. 5, 669-676.
112. Gadhoum, Z., Leibovitch, M. P., Qi, J., Dumenil, D., Durand, L., Leibovitch, S., Smadja-Joffe, F. (2004) CD44: a new means to inhibit acute myeloid leukemia cell proliferation via p27Kip1. Blood 103, 1059-1068.
113. Jin, L., Hope, K. J., Zhai, Q., Smadja-Joffe, F., Dick, J. E. (2006) Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat. Med. 12, 1167-1174.
114. Krause, D. S., Lazarides, K., von Andrian, U. H., Van Etten, R. A. (2006) Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat. Med. 12, 1175-1180.
115. Ghaffari, S., Smadja-Joffe, F., Oostendorp, R., Levesque, J. P., Dougherty, G., Eaves, A., Eaves, C. (1999) CD44 isoforms in normal and leukemic hematopoiesis. Exp. Hematol. 27, 978-993.
116. Ishikawa, F., Yoshida, S., Saito, Y., Hijikata, A., Kitamura, H., Tanaka, S., Nakamura, R., Tanaka, T., Tomiyama, H., Saito, N., Fukata, M., Miyamoto, T., Lyons, B., Ohshima, K., Uchida, N., Taniguchi, S., Ohara, O., Akashi, K., Harada, M., Shultz, L. D. (2007) Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat. Biotechnol. 25, 1315-1321.
117. Saito, Y., Kitamura, H., Hijikata, A., Tomizawa-Murasawa, M., Tanaka, S., Takagi, S., Uchida, N., Suzuki, N., Sone, A., Najima, Y., Ozawa, H., Wake, A., Taniguchi, S., Shultz, L. D., Ohara, O., Ishikawa, F. (2010) Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells. Sci. Transl. Med. 2, 17ra19.
118. Kobbe, G., Bauser, U., Rieth, C., Hunerliturkoglu, A., Sohngen, D., Aivado, M., Aul, C., Heyll, A. (1998) Granulocyte colony-stimulating factor (G-CSF) mediated mobilization of leukemic cells in Philadelphia chromosome positive acute lymphoblastic leukemia expressing myeloid antigens (my+Ph+ALL). Am. J. Hematol. 58, 330-333.
119. Andreeff, M., Konoplev, S., Wong, R-Y., Zeng, Z., McQueen, T., Shi, Y-X., Medeiros, L. J., Estey, E., McCarty, J. M., Elkins, S., Champlin, R., Calandra, G., Bridger, G., Konopleva, M. (2006) Massive mobilization of AML cells into circulation by disruption of leukemia/stroma cell interactions using CXCR4 antagonist AMD3100: first evidence in patients and potential for abolishing bone marrow microenvironment-mediated resistance. Blood (ASH Annual Meeting Abstracts) 108, Abs. 568.
120. Allouche, M., Charrad, R. S., Bettaieb, A., Greenland, C., Grignon, C., Smadja-Joffe, F. (2000) Ligation of the CD44 adhesion molecule inhibits drug-induced apoptosis in human myeloid leukemia cells. Blood 96, 1187-1190.
121. Charrad, R. S., Gadhoum, Z., Qi, J., Glachant, A., Allouche, M., Jasmin, C., Chomienne, C., Smadja-Joffe, F. (2002) Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood 99, 290-299.
122. Becker, P. S., Chien, S., Roshal, M., Wood, B., Estey, E., Papayannopoulou, T., Zhao, X., Basu, S., McGrath, M., Kopecky, K., Appelbaum, F. R. (2009) Adhesion receptor expression by acute myeloid leukemia (AML) bone marrow derived or circulating blasts and AML stem cells: the key to overcoming chemoresistance. Blood (ASH Annual Meeting Abstracts) 114, Abs. 2658.
123. Frenette, P. S., Subbarao, S., Mazo, I. B., von Andrian, U. H., Wagner, D. D. (1998) Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow. Proc. Natl. Acad. Sci. USA 95, 14423-14428.
124. Kortlepel, K., Bendall, L. J., Gottlieb, D. J. (1993) Human acute myeloid leukaemia cells express adhesion proteins and bind to bone marrow fibroblast monolayers and extracellular matrix proteins. Leukemia 7, 1174-1179.
125. Valenzuela-Fernández, A., Planchenault, T., Baleux, F., Staropoli, I., Le-Barillec, K., Leduc, D., Delaunay, T., Lazarini, F., Virelizier, J. L., Chignard, M., Pidard, D., Arenzana-Seisdedos, F. (2002) Leukocyte elastase negatively regulates stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J. Biol. Chem. 277, 15677-15689.
126. Levesque, J. P., Liu, F., Simmons, P. J., Betsuyaku, T., Senior, R. M., Pham, C., Link, D. C. (2004) Characterization of hematopoietic progenitor mobilization in protease-deficient mice. Blood 104, 65-72.
127. Bendall, L. J., Kortlepel, K., Gottlieb, D. J. (1993) Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of β-1 and β-2 integrin mechanisms. Blood 82, 3125-3132.
128. Watanabe, T., Dave, B., Heimann, D. G., Lethaby, E., Kessinger, A., Talmadge, J. E. (1997) GM-CSF-mobilized peripheral blood CD34+ cells differ from steady-state bone marrow CD34+ cells in adhesion molecule expression. Bone Marrow Transplant. 19, 1175-1181.
129. Lévesque, J. P., Leavesley, D. I., Niutta, S., Vadas, M., Simmons, P. J. (1995) Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J. Exp. Med. 181, 1805-1815.
130. Devine, S. M., Brown, R. A., Mathews, V., Trinkaus, K., Khoury, H., Adkins, D., Vij, R., Sempek, D., Graubert, T., Tomasson, M., Goodnough, L. T., DiPersio, J. F. (2005) Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone. Bone Marrow Transplant. 36, 531-538.
131. Nervi, B., Ramirez, P., Rettig, M. P., Uy, G. L., Holt, M. S., Ritchey, J. K., Prior, J. L., Piwnica-Worms, D., Bridger, G., Ley, T. J., Dipersio, J. F. (2009) Chemosensitization of AML following mobilization by the CXCR4 antagonist AMD3100. Blood 113, 6206-6214.
132. Westervelt, P., Lane, A. A., Pollock, J. L., Oldfather, K., Holt, M. S., Zimonjic, D. B., Popescu, N. C., DiPersio, J. F., Ley, T. J. (2003) High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARα expression. Blood 102, 1857-1865.
133. Liesveld, J. L., Bechelli, J., Rosell, K., Lu, C., Bridger, G., Phillips II, G Abboud C. (2007) Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells. Leuk. Res. 31, 1553-1563.
134. Uy, G. L., Rettig, M. P., McFarland, K., Hladnik, L., Kulkarni, S., Abboud, C. N., Cashen, A. F., Stockerl-Goldstein, K., Vij, R., Westervelt, P., Dipersio, J. F. (2009) A phase I/II study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory AML. Blood (ASH Annual Meeting Abstracts) 114, Abs. 787.
135. Zeng, Z., Shi, Y. X., Samudio, I. J., Wang, R. Y., Ling, X., Frolova, O., Levis, M., Rubin, J. B., Negrin, R. R., Estey, E. H., Konoplev, S., Andreeff, M., Konopleva, M. (2009) Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML. Blood 113, 6215-6224.
136. Juarez, J., Dela Pena, A., Baraz, R., Hewson, J., Khoo, M., Cisterne, A., Fricker, S., Fujii, N., Bradstock, K. F., Bendall, L. J. (2007) CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment. Leukemia 21, 1249-1257.
137. Bradstock, K. F., Makrynikola, V., Bianchi, A., Shen, W., Hewson, J., Gottlieb, D. J. (2000) Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers. Leukemia 14, 882-888.
138. Spiegel, A., Kollet, O., Peled, A., Abel, L., Nagler, A., Bielorai, B., Rechavi, G., Vormoor, J., Lapidot, T. (2004) Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling. Blood 103, 2900-2907.
139. Juarez, J., Bradstock, K. F., Gottlieb, D. J., Bendall, L. J. (2003) Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro. Leukemia 17, 1294-1300.
140. Burger, M., Hartmann, T., Krome, M., Rawluk, J., Tamamura, H., Fujii, N., Kipps, T. J., Burger, J. A. (2005) Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. Blood 106, 1824-1830.